Published in Diabetologia on October 01, 1998
The Effects of Anti-Inflammatory Treatment on Insulin Resistance in Healthy Volunteers | NCT00339833
Obesity is associated with macrophage accumulation in adipose tissue. J Clin Invest (2003) 41.22
Chronic inflammation in fat plays a crucial role in the development of obesity-related insulin resistance. J Clin Invest (2003) 32.01
Inflammation and insulin resistance. J Clin Invest (2006) 18.76
Local and systemic insulin resistance resulting from hepatic activation of IKK-beta and NF-kappaB. Nat Med (2005) 10.88
Mechanisms for insulin resistance: common threads and missing links. Cell (2012) 6.85
Insulin resistance, lipotoxicity, type 2 diabetes and atherosclerosis: the missing links. The Claude Bernard Lecture 2009. Diabetologia (2010) 3.17
Circulating TNF receptors 1 and 2 predict ESRD in type 2 diabetes. J Am Soc Nephrol (2012) 2.75
Ten putative contributors to the obesity epidemic. Crit Rev Food Sci Nutr (2009) 2.71
Central role of suppressors of cytokine signaling proteins in hepatic steatosis, insulin resistance, and the metabolic syndrome in the mouse. Proc Natl Acad Sci U S A (2004) 2.54
Tuberculosis in poorly controlled type 2 diabetes: altered cytokine expression in peripheral white blood cells. Clin Infect Dis (2008) 2.24
The adipocyte as an endocrine cell. Endocrinol Metab Clin North Am (2008) 2.20
Protein-tyrosine phosphatase 1B expression is induced by inflammation in vivo. J Biol Chem (2008) 2.08
Interleukin-10 prevents diet-induced insulin resistance by attenuating macrophage and cytokine response in skeletal muscle. Diabetes (2009) 2.00
Association of C-reactive protein with type 2 diabetes: prospective analysis and meta-analysis. Diabetologia (2009) 1.96
Blockade of RAGE suppresses periodontitis-associated bone loss in diabetic mice. J Clin Invest (2000) 1.82
Cognitive impairment following high fat diet consumption is associated with brain inflammation. J Neuroimmunol (2009) 1.82
Elevated proinflammatory cytokine production by a skewed T cell compartment requires monocytes and promotes inflammation in type 2 diabetes. J Immunol (2010) 1.78
Oxidative stress in type 2 diabetes: the role of fasting and postprandial glycaemia. Int J Clin Pract (2006) 1.78
Probiotics improve high fat diet-induced hepatic steatosis and insulin resistance by increasing hepatic NKT cells. J Hepatol (2008) 1.78
Role of leptin as an immunomodulator of blood mononuclear cells: mechanisms of action. Clin Exp Immunol (2003) 1.65
PPARs are a unique set of fatty acid regulated transcription factors controlling both lipid metabolism and inflammation. Biochim Biophys Acta (2011) 1.60
The effect of salsalate on insulin action and glucose tolerance in obese non-diabetic patients: results of a randomised double-blind placebo-controlled study. Diabetologia (2008) 1.49
Intimal redox stress: accelerated atherosclerosis in metabolic syndrome and type 2 diabetes mellitus. Atheroscleropathy. Cardiovasc Diabetol (2002) 1.46
Sib-recruitment for studying migration and its impact on obesity and diabetes. Emerg Themes Epidemiol (2006) 1.38
What is metabolic syndrome, and why are children getting it? Ann N Y Acad Sci (2013) 1.38
Expansion of pathogen-specific T-helper 1 and T-helper 17 cells in pulmonary tuberculosis with coincident type 2 diabetes mellitus. J Infect Dis (2013) 1.36
Impact of the gut microbiota on the development of obesity and type 2 diabetes mellitus. Front Microbiol (2014) 1.35
The interleukin-6 (-174) G/C promoter polymorphism is associated with type-2 diabetes mellitus in Native Americans and Caucasians. Hum Genet (2003) 1.31
Gut microbiota and diabetes: from pathogenesis to therapeutic perspective. Acta Diabetol (2011) 1.30
Type 2 diabetes mellitus and inflammation: Prospects for biomarkers of risk and nutritional intervention. Diabetes Metab Syndr Obes (2010) 1.28
Getting away from glucose: fanning the flames of obesity-induced inflammation. Nat Med (2009) 1.28
Central nervous system mechanisms linking the consumption of palatable high-fat diets to the defense of greater adiposity. Cell Metab (2012) 1.23
Evidence for activation of inflammatory lipoxygenase pathways in visceral adipose tissue of obese Zucker rats. Am J Physiol Endocrinol Metab (2010) 1.20
Complement factor H is expressed in adipose tissue in association with insulin resistance. Diabetes (2009) 1.19
Immunological mechanisms contributing to the double burden of diabetes and intracellular bacterial infections. Immunology (2015) 1.17
Neutrophils and monocytes as potentially important sources of proinflammatory cytokines in diabetes. Clin Exp Immunol (2006) 1.16
Curcumin and resveratrol inhibit nuclear factor-kappaB-mediated cytokine expression in adipocytes. Nutr Metab (Lond) (2008) 1.15
Vitamins D, C, and E in the prevention of type 2 diabetes mellitus: modulation of inflammation and oxidative stress. Biologics (2011) 1.13
Obesity and inflammation: epidemiology, risk factors, and markers of inflammation. Int J Endocrinol (2013) 1.12
Elevated C-reactive protein levels and metabolic syndrome in the elderly: The role of central obesity data from the InChianti study. Atherosclerosis (2008) 1.12
CD14 modulates inflammation-driven insulin resistance. Diabetes (2011) 1.11
Hypothalamic inflammation: a double-edged sword to nutritional diseases. Ann N Y Acad Sci (2011) 1.11
Evaluation of TNF-α and IL-6 Levels in Obese and Non-obese Diabetics: Pre- and Postinsulin Effects. N Am J Med Sci (2012) 1.10
Type 2 diabetes mellitus coincident with pulmonary tuberculosis is associated with heightened systemic type 1, type 17, and other proinflammatory cytokines. Ann Am Thorac Soc (2013) 1.08
Diabetic periodontitis: a model for activated innate immunity and impaired resolution of inflammation. Periodontol 2000 (2007) 1.08
Onion peel extracts ameliorate hyperglycemia and insulin resistance in high fat diet/streptozotocin-induced diabetic rats. Nutr Metab (Lond) (2011) 1.06
Sedentary time and markers of chronic low-grade inflammation in a high risk population. PLoS One (2013) 1.05
Effect of acute hyperglycaemia and/or hyperinsulinaemia on proinflammatory gene expression, cytokine production and neutrophil function in humans. Diabet Med (2008) 1.02
Cytokine secretion in long-standing diabetes mellitus type 1 and 2: associations with low-grade systemic inflammation. J Clin Immunol (2008) 1.02
Inflammatory cytokines in diabetic nephropathy. J Diabetes Res (2015) 1.01
The usefulness of circulating adipokine levels for the assessment of obesity-related health problems. Int J Med Sci (2008) 0.99
Low adiponectin concentration during pregnancy predicts postpartum insulin resistance, beta cell dysfunction and fasting glycaemia. Diabetologia (2009) 0.99
Dietary fatty acids modulate antigen presentation to hepatic NKT cells in nonalcoholic fatty liver disease. J Lipid Res (2010) 0.99
NOX2 deficiency attenuates markers of adiposopathy and brain injury induced by high-fat diet. Am J Physiol Endocrinol Metab (2012) 0.98
Association between IL-6 and the extent of coronary atherosclerosis in the veterans affairs diabetes trial (VADT). Atherosclerosis (2008) 0.98
Diminished systemic and antigen-specific type 1, type 17, and other proinflammatory cytokines in diabetic and prediabetic individuals with latent Mycobacterium tuberculosis infection. J Infect Dis (2014) 0.98
Relationship between sialic acid and metabolic variables in Indian type 2 diabetic patients. Lipids Health Dis (2005) 0.97
Immunosupportive therapies in aging. Clin Interv Aging (2007) 0.97
Genetic polymorphisms of innate immunity-related inflammatory pathways and their association with factors related to type 2 diabetes. BMC Med Genet (2011) 0.96
The NuGO proof of principle study package: a collaborative research effort of the European Nutrigenomics Organisation. Genes Nutr (2008) 0.96
B cells as under-appreciated mediators of non-auto-immune inflammatory disease. Cytokine (2010) 0.93
Differential effects of interleukin-13 and interleukin-6 on Jak/STAT signaling and cell viability in pancreatic β-cells. Islets (2013) 0.93
Insulin resistance, metabolic stress, and atherosclerosis. Front Biosci (Schol Ed) (2012) 0.93
The prospective association of socioeconomic status with C-reactive protein levels in the CARDIA study. Brain Behav Immun (2012) 0.93
Molecular mechanisms of obesity and diabetes: at the intersection of weight regulation, inflammation, and glucose homeostasis. World J Surg (2009) 0.92
Frequency of TLR 2, 4, and 9 gene polymorphisms in Chinese population and their susceptibility to type 2 diabetes and coronary artery disease. J Biomed Biotechnol (2012) 0.91
Inflammation in diabetic kidney disease. World J Diabetes (2014) 0.91
Evidence for the gut microbiota short-chain fatty acids as key pathophysiological molecules improving diabetes. Mediators Inflamm (2014) 0.91
Brd2 gene disruption causes "metabolically healthy" obesity: epigenetic and chromatin-based mechanisms that uncouple obesity from type 2 diabetes. Vitam Horm (2013) 0.90
Large-scale association analysis of TNF/LTA gene region polymorphisms in type 2 diabetes. BMC Med Genet (2010) 0.90
Analysis of inflammatory mediators in type 2 diabetes patients. Int J Endocrinol (2013) 0.90
Type 2 diabetes mellitus is associated with altered CD8(+) T and natural killer cell function in pulmonary tuberculosis. Immunology (2015) 0.90
Plasma interleukin 8 concentrations in obese subjects with impaired glucose tolerance. Cardiovasc Diabetol (2003) 0.90
Inflammatory cytokines in general and central obesity and modulating effects of physical activity. PLoS One (2015) 0.90
Metabolic syndrome and obesity in an insect. Proc Natl Acad Sci U S A (2006) 0.89
Association of a promoter variant in the inducible cyclooxygenase-2 gene (PTGS2) with type 2 diabetes mellitus in Pima Indians. Hum Genet (2003) 0.88
Type 2 diabetes mellitus: From a metabolic disorder to an inflammatory condition. World J Diabetes (2015) 0.87
Infection and inflammation in somatic maintenance, growth and longevity. Evol Appl (2009) 0.87
A 12-week regimen of caloric restriction improves levels of adipokines and pro-inflammatory cytokines in Korean women with BMIs greater than 23 kg/m2. Inflamm Res (2009) 0.87
Resveratrol increases glucose induced GLP-1 secretion in mice: a mechanism which contributes to the glycemic control. PLoS One (2011) 0.86
Rarity of TLR4 Asp299Gly and Thr399Ile polymorphisms in the Korean population. Yonsei Med J (2008) 0.86
Antifibrotic treatment and other new strategies for improving renal outcomes. Contrib Nephrol (2011) 0.86
Burkholderia pseudomallei triggers altered inflammatory profiles in a whole-blood model of type 2 diabetes-melioidosis comorbidity. Infect Immun (2012) 0.86
Impaired dendritic cell functions disrupt antigen-specific adaptive immune responses in mice with nonalcoholic fatty liver disease. J Gastroenterol (2010) 0.86
Role of adipokines and other inflammatory mediators in gestational diabetes mellitus and previous gestational diabetes mellitus. Int J Endocrinol (2012) 0.85
Fish consumption, low-level mercury, lipids, and inflammatory markers in children. Environ Res (2011) 0.84
Analyte flux at a biomaterial-tissue interface over time: implications for sensors for type 1 and 2 diabetes mellitus. J Diabetes Sci Technol (2010) 0.84
Common variations in the genes encoding C-reactive protein, tumor necrosis factor-alpha, and interleukin-6, and the risk of clinical diabetes in the Women's Health Initiative Observational Study. Clin Chem (2010) 0.84
Hypertension in obese type 2 diabetes patients is associated with increases in insulin resistance and IL-6 cytokine levels: potential targets for an efficient preventive intervention. Int J Environ Res Public Health (2014) 0.84
Association between circulating ascorbic acid, α-tocopherol, 25-hydroxyvitamin D, and plasma cytokine concentrations in young adults: a cross-sectional study. Nutr Metab (Lond) (2012) 0.84
Interleukin-6, high sensitivity C-reactive protein, and the development of type 2 diabetes among HIV-positive patients taking antiretroviral therapy. J Acquir Immune Defic Syndr (2014) 0.84
The Antidiabetic Effect of Garlic Oil is Associated with Ameliorated Oxidative Stress but Not Ameliorated Level of Pro-inflammatory Cytokines in Skeletal Muscle of Streptozotocin-induced Diabetic Rats. J Tradit Complement Med (2012) 0.84
Tight association between macrophages and adipocytes in obesity: implications for adipocyte preparation. Obesity (Silver Spring) (2013) 0.84
Eosinophil inversely associates with type 2 diabetes and insulin resistance in Chinese adults. PLoS One (2013) 0.84
Clinical analysis of selected complement-derived molecules in human adipose tissue. J Transl Med (2013) 0.83
Association between C-reactive protein and type 2 diabetes in a Tunisian population. Inflammation (2012) 0.83
Association of CRP gene polymorphism with CRP levels and Coronary Artery Disease in Type 2 Diabetes in Ahvaz, southwest of Iran. Bioimpacts (2014) 0.83
CD14 deficiency impacts glucose homeostasis in mice through altered adrenal tone. PLoS One (2012) 0.83
Association of C-reactive protein, interleukin-1 receptor antagonist and adiponectin with the metabolic syndrome. Mediators Inflamm (2007) 0.83
Effect of atorvastatin on plasma fibrinogen. Lancet (1998) 3.35
A prospective case-controlled cohort study of endothelial function in patients with moderate to severe psoriasis. Br J Dermatol (2010) 2.04
Hypomagnesaemia in IDDM patients with microalbuminuria and clinical proteinuria. Diabetologia (1994) 1.50
Hyperferritinaemia; laboratory implications. Ann Clin Biochem (2012) 1.41
Comparison of therapy with simvastatin 80 mg and atorvastatin 80 mg in patients with familial hypercholesterolaemia. Int J Clin Pract (1999) 1.39
More on the effect of atorvastatin on plasma fibrinogen levels in primary hypercholesterolaemia. Atherosclerosis (2000) 1.39
A comparison of algorithms for initiation of lipid lowering therapy in primary prevention of coronary heart disease. J Cardiovasc Risk (2000) 1.18
Blood glucose and glycated haemoglobin measurement in hospital: which method? Diabet Med (1993) 1.07
Apolipoprotein E gene polymorphisms are associated with psoriasis but do not determine disease response to acitretin. Br J Dermatol (2006) 1.04
Lipoprotein X: clinical implications. Ann Clin Biochem (2013) 0.96
Atorvastatin compared with simvastatin-based therapies in the management of severe familial hyperlipidaemias. QJM (1999) 0.96
Elevated sialic acid, but not CRP, predicts features of the metabolic syndrome independently of BMI in women. Int J Obes Relat Metab Disord (2004) 0.96
Serum sialic acid concentration and coronary heart disease in NIDDM. Diabetes Care (1995) 0.88
Serum sialic acid and the long-term complications of insulin-dependent diabetes mellitus. Diabet Med (1996) 0.86
The Caldicott report and patient confidentiality. J Clin Pathol (2003) 0.85
Renin-angiotensin system polymorphisms and coronary events in familial hypercholesterolemia. Hypertension (2000) 0.83
Serum sialic acid as an indicator of change in coronary artery disease. Metabolism (1995) 0.81
Doege-Potter syndrome and 'big-IGF2': a rare cause of hypoglycaemia. Ann Clin Biochem (2011) 0.80
Severe hypertriglyceridaemia in Type 2 diabetes mellitus: beneficial effect of continuous insulin infusion. QJM (2013) 0.79
Lipid lowering therapy in patients with HIV infection. Lancet (1998) 0.78
Plasma sialic acid and coronary artery atheromatous load in patients with stable chest pain. Atherosclerosis (1999) 0.78
Serum sialic acid enzymatic assay based on microtitre plates: application for measuring capillary serum sialic acid concentrations. Br J Biomed Sci (1993) 0.77
The response of serum apolipoprotein H to an oral fat load. Ann Clin Biochem (2004) 0.77
Fenofibrate plus simvastatin therapy versus simvastatin plus cholestyramine therapy for familial hypercholesterolaemia. QJM (1997) 0.76
The response of serum sialic acid and other acute phase reactants to an oral fat load in healthy humans. Eur J Intern Med (2001) 0.76
Severe hypertriglyceridemia complicating pregnancy, management by dietary intervention and omega-3 fatty acid supplementation. Nutrition (2009) 0.76
Rimonabant improves cholesterol, insulin resistance and markers of non-alcoholic fatty liver in morbidly obese patients: a retrospective cohort study. Int J Clin Pract (2011) 0.76
Potassium EDTA contamination of blood samples: a warning. Int J Clin Pract (2009) 0.75
Refeeding syndrome still needs to be recognized and managed appropriately. Nutrition (2008) 0.75
Lowering cholesterol. J R Coll Physicians Lond (2000) 0.75
Iron status, movement disorders, and acute phase response in elderly psychiatric patients. J Neurol Neurosurg Psychiatry (1994) 0.75
Closing in on the gaps. Ann Clin Biochem (2010) 0.75
Paradoxical decrease in serum high-density lipoprotein cholesterol and lipid-lowering drugs. Ann Clin Biochem (2011) 0.75
Thrombotic vascular events after change of statin. Lancet (1999) 0.75
Are drugs interchangeable? Lancet (2000) 0.75
People at risk of coronary heart disease should not be denied treatment with effective drugs for purely financial reasons. BMJ (1998) 0.75
The refeeding syndrome and hypophosphataemia in the elderly. J Intern Med (2005) 0.75
Measurement of atherosclerosis progression. Lancet (2001) 0.75
Natural statins and stroke. Circulation (2000) 0.75
Bile salts and obesity. Ann Clin Biochem (2010) 0.75
Metabolic syndrome and risk of coronary heart disease in a Pakistani cohort. Heart (2005) 0.75
Hypoalbuminemia: the importance of correct interpretation. Nutrition (2009) 0.75
Bone marrow transplantation and severe hypophosphataemia. Br J Haematol (1996) 0.75
Organic-metal toxicity and total parenteral nutrition. Nutrition (2001) 0.75
Sialic acid and heart disease. BMJ (1993) 0.75
Cholestatic liver dysfunction. Lancet (1999) 0.75
A place for assaying serum apolipoprotein AI and B? Ann Clin Biochem (2011) 0.75
Lipaemia: causes, consequences and solutions. Clin Chim Acta (2013) 0.75
Differing relationships of methylene tetrahydrofolate reductase genotypes with cardiovascular risk in familial and polygenic hypercholesterolaemia. J Cardiovasc Risk (2000) 0.75
Serum antioxidant status in hypobetalipoproteinaemia. Atherosclerosis (1997) 0.75
High-density lipoprotein cholesterol and triglyceride response with simvastatin versus atorvastatin in familial hypercholesterolemia. Am J Cardiol (2000) 0.75
Chemical pathology: what has changed? J Clin Pathol (2000) 0.75
Growth hormone (GH) replacement therapy reduces serum sialic acid concentrations in adults with GH-deficiency: a double-blind placebo-controlled study. Clin Endocrinol (Oxf) (1999) 0.75
The lipaemic index: clinical observations. Br J Biomed Sci (2015) 0.75
Angiographic coronary artery disease and high-sensitivity troponin-T in a native Pakistani cohort presenting with chronic chest pain. Int J Clin Pract (2014) 0.75
High-dose atorvastatin therapy in severe heterozygous familial hypercholesterolaemia. QJM (1998) 0.75
Insulin resistance phenotypes and coronary artery disease in a native Pakistani cohort. Int J Clin Pract (2008) 0.75
Electrokinetic properties of human cryopreserved platelets. Transfus Med (1994) 0.75
Fibrinogen response with simvastatin versus atorvastatin in familial hypercholesterolemia. Am J Cardiol (2001) 0.75
Low serum creatine kinase activity in hospital patients. Br J Biomed Sci (2015) 0.75
Influence of sialic acid content of low-density lipoprotein particles on endothelium-dependent vasorelaxation in rabbit aorta. Atherosclerosis (2001) 0.75